Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
- DOI
- 10.1128/aac.01305-25
- Published
- 2026 Mar 4
- Container
- Antimicrobial agents and chemotherapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/aac.01305-25,
title = {Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.},
author = {Kang HJ and Arrieta AC and Dhooge C and Kelemen Á and Macías-Parra M and Aranda L and Dinikina YV and Kassis I and Cesaro S and Shepherd A and Shah AK and Mackey T and Waskin H and Johnson MG},
year = {2026},
journal = {Antimicrobial agents and chemotherapy},
doi = {10.1128/aac.01305-25},
url = {https://doi.org/10.1128/aac.01305-25}
}RIS
TY - JOUR TI - Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease. AU - Kang HJ AU - Arrieta AC AU - Dhooge C AU - Kelemen Á AU - Macías-Parra M AU - Aranda L AU - Dinikina YV AU - Kassis I AU - Cesaro S AU - Shepherd A AU - Shah AK AU - Mackey T AU - Waskin H AU - Johnson MG PY - 2026 JO - Antimicrobial agents and chemotherapy DO - 10.1128/aac.01305-25 UR - https://doi.org/10.1128/aac.01305-25 ER -
APA
HJ, K., AC, A., C, D., Á, K., M, M., L, A., YV, D., I, K., S, C., A, S., AK, S., T, M., H, W., & MG, J. (2026). Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.01305-25
Source records
- pubmed · retrieved 2026-09-25T08:59:27.896Z